0 CHECKOUT

PRODUCT FILTERS

REGION

39
9
8
7
3

COUNTRY

8
2
1
1

CATEGORIES

  • 219
  • 38
  • 15
  • 7
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

15
148
227
320

PUBLISHED

1
26
70
320

PRODUCT TYPE

205
98
14
1
1
1

Search for: "Alzheimer Disease Therapy Area Pipeline Report"

Global Alzheimer’s Disease Drugs Market & Pipeline Drugs Market Analysis to 2020

Alzheimer’s disease is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global...

Published:  July 2015
Price:  From

Alzheimer's Disease - Pipeline Review, H1 2016

Alzheimer’s Disease - Pipeline Review, H1 2016 Summary ‘Alzheimer’s Disease - Pipeline Review, H1 2016’, provides an overview of the Alzheimer’s Disease pipeline landscape. The report provides comprehensive...

Published:  March 2016
Price:  From

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

The global market for AD therapeutics and diagnostics by region should reach over $6.2 billion by 2020 from $4.4 billion in 2015, at a compound annual growth rate (CAGR) of 7.1% from 2015 to 2020. This...

Published:  March 2016
Price:  From

Alzheimer's Disease - Pipeline Review, H2 2015

Alzheimer's Disease - Pipeline Review, H2 2015 Summary The report ‘Alzheimer's Disease - Pipeline Review, H2 2015’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This report...

Published:  December 2015
Price:  From

Alzheimer's Pipeline Drugs Review, Alzheimer's Disease Drug Market & Forecast – Global Analysis

Alzheimer's disease drug market is on the curvature stage Since 2003, there is not any single “magic bullet” launched in the market to prevent or cure it However, all current marketed products are going...

Published:  December 2013
Price:  From

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

Published:  April 2016
Price:  From

Aricept (Alzheimer's disease) - Analysis and Forecasts to 2022

Aricept (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “Aricept (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides Aricept global...

Published:  April 2012
Price:  From

Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2015

Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2015 Summary The report ‘Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2015’, provides an overview of the Dementia...

Published:  November 2015
Price:  From

Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2015

Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2015 Summary This, ‘Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2015’, provides an overview of the Dementia...

Published:  April 2015
Price:  From

Gammagard Liquid (Alzheimer's disease) - Analysis and Forecasts to 2022

Gammagard Liquid (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “Gammagard Liquid (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides...

Published:  April 2012
Price:  From

Namenda (Alzheimer's disease) - Analysis and Forecasts to 2022

Namenda (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “Namenda (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides Namenda global...

Published:  April 2012
Price:  From

LY2062430 (Alzheimer's disease) - Analysis and Forecasts to 2022

LY2062430 (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “LY2062430 (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides LY2062430...

Published:  April 2012
Price:  From

US CNS Disorders Drug Pipeline Insight 2014

The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. The numbers of CNS disorders have increased at an alarming rate, while the available...

Published:  August 2014
Price:  From

Alzheimer's Disease - Pipeline Review, H1 2015

Alzheimer's Disease - Pipeline Review, H1 2015 Summary This, ‘Alzheimer's Disease - Pipeline Review, H1 2015’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This report...

Published:  January 2015
Price:  From

AAB-001 (bapineuzumab) (Alzheimer's disease) - Analysis and Forecasts to 2022

AAB-001 (bapineuzumab) (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “AAB-001 (bapineuzumab) (Alzheimer’s disease) – Analysis and Forecasts to...

Published:  April 2012
Price:  From

Alzheimer's Drugs Market, 2012 - 2017

Alzheimer's disease is a neurodegenerative disease of the brain which leads to loss of memory and cognitive functions With ageing world population, the number of patients suffering from Alzheimer's...

Published:  May 2013
Price:  From

Global Alzheimer's Drugs Market 2014-2018

Alzheimer's disease is a progressive, irreversible degeneration of the brain that disrupts the thinking, language, behavioral and cognitive skills of a person. AD is more prevalent in people aged 65...

Published:  June 2014
Price:  From

Early-Stage Minimally-Invasive Biomarkers in Alzheimer's Disease: A Comprehensive Analysis and Market Study of New Developments and Opportunities, 2014

REPORT DESCRIPTION This report is a comprehensive analysis and market study of new developments relating to early-stage minimally-invasive biomarkers in Alzheimer's disease, which have been 'functionally...

Published:  August 2014
Price:  From

Alzheimer's Disease Autoantibodies, Vaccines and Therapeutic Antibodies Pipeline, 2011

This report presents a comprehensive review of autoantibodies, and pipeline vaccines and therapeutic antibodies, in Alzheimer's disease (AD) Currently, drug treatments for AD are dominated by cholinesterase...

Published:  March 2011
Price:  From

Intra-Cellular Therapies, Inc. - Product Pipeline Review - 2015

Intra-Cellular Therapies, Inc. - Product Pipeline Review - 2015 Summary This, ‘Intra-Cellular Therapies, Inc. - Product Pipeline Review - 2015’, provides an overview of the Intra-Cellular Therapies,...

Published:  April 2015
Price:  From
Loading Indicator

Our Clients

  • Goodyear Tire & Rubber Company
  • GlaxoSmithKline PLC
  • Hilton Worldwide
  • Hewlett-Packard Company
  • Accenture PLC.
  • Qualcomm Incorporated
  • UBS AG